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Abstract

In this paper, we present a model for imputing timing of mother-tochild transmission (MTCT) of HIV. The method reflects the three modes
of MTCT of HIV: in utero, during delivery and via breastfeeding and can
accomodate shapes for the baseline hazard that vary between infants. Additionally, it allows that the majority of infants do not experience MTCT
of HIV. Final analyses from the imputed data sets are combined in a multiple imputation framework. The methods is illustrated on a large trial
designed to assess the use of antibiotics in preventing MTCT of HIV and is
validated using simulations. Additionally, we explore appropriate censoring
techniques to account for weaning.
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Introduction

There is great interest in understanding the dynamics of mother to child transmission (MTCT). This includes estimating MTCT rates during the three exposure
periods (in utero, intrapartum and postnatal (while breastfeeding)), estimating
the relationship between baseline covariates and the likelihood of transmission in
each of the exposure periods, estimating the distribution of the timing of MTCT
overall or within one of the exposure periods and relating distributions of the timing of MTCT to baseline covariates [e.g., 27, 12, 13, 15, 18, 21]. Unfortunately,
infants are often lost to follow-up, frequently due to death of the infant or mother,
moving away from the study site or unwillingness of the primary caregiver to allow
the infant to continue in the study. These infants often have an unknown infection
status at the end of the study. Also, because HIV-1 infection is only assessed at
discrete points in time (usually during routine clinic visits), the time of infection
is only known within an interval. Missed visits can also complicate analyses.
The HIV Prevention Trials Network (HPTN) 024 study was a multisite, placebocontrolled, double blinded randomized trial of antibiotics to prevent perinatal
MTCT of HIV-1 [26]. In trials such as HPTN 024, the primary endpoint is often
the cumulative transmission rate at a point in time shortly after birth. In HPTN
024 and most MTCT studies, the infants were scheduled to be tested within 48
hours after birth to assess in utero transmission. A second visit was scheduled to
be between 4 and 8 weeks after birth to assess intrapartum transmission. Subsequent visits were also scheduled to evaluate late postnatal MTCT of HIV-1 via
breast milk (transmission first detected after 6 weeks) and mortality. Specifically
in HPTN 024, these visits were scheduled at 3, 6, 9 and 12 months. The usual
2
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approach to estimate the distribution of the timing of MTCT of HIV-1 via breast
milk is to subset the data to breastfed infants known to be negative at the 4-8
week visit because they tested negative at that or a later visit. Infants who missed
the 4-8 week visit and subsequently tested positive would not be included in the
analysis because their 4-8 week HIV-1 infection status is unknown. If interest is in
estimation of the survival curve, then the origin is set to 8 weeks and the infant’s
time to event is taken to be the time of the first positive test or the midpoint
between the last negative test and the first positive test. If the infant has no
positive test, his time to event is censored at the last negative test, weaning or
death. Hughes and Richardson [11] proposed nonparametric and semiparametric
approaches for estimating the HIV-1 infection time in infants; however, these approaches do not allow for covariates. Other general interval-censoring techniques
may also be used to estimate the survival distribution [29, 23] or hazard ratios
[7, 22, 9]. However, none of these approaches account for uncertainty about inclusion of some infants in subset analyses nor do they reflect the unique features
of the distribution of the timing of MTCT of HIV which we will detail later.
Multiple imputation [20] has previously been proposed to aid in the analysis of
interval-censored data. Pan [17] proposed an imputation scheme based on the Poor
Man’s Data Augmentation algorithm [30]. Bebchuk and Betensky [1] used local
likelihood methods for imputing interval censored observations. Neither of these
approaches made use of auxilliary information nor did they impute right-censored
observations. Glynn and Rosner [8] proposed a multiple imputation scheme for
interval censored paired data based on a parametric frailty model. Most recently,
Hsu et al. [10] proposed a non-parametric imputation approach that uses auxilliary
variables and imputes both right and interval censored observations.
3
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In this paper, we present a flexible model for imputing the timing of MTCT of
HIV-1. This model allows that a proportion of infants are born with detectable
HIV-1 infection from in utero transmission and that another significant proportion
will never experience MTCT of HIV. It also allows for a flexible estimate of the
hazard for postnatal transmission while still allowing for straight-forward computation using available software. Additionally, we demonstrate how to use this
model to impute transmission times both for right and interval censored observations. Finally, we use multiple imputation methods to calculate the final estimates
and their standard errors. An application of this approach to the HPTN 024 data
set demonstrates the value of this approach to estimate the distribution of timing
of late postnatal transmission. An extensive simulation explores the properties of
the MI procedure.

2
2.1

Methods
Overview

Let s denote the time that an infant would first test positive for HIV-1 (referred
to as timing of MTCT). Note that this is not the same as the time at which of
MTCT of HIV-1 occurs due to the low sensitivity of HIV-1 PCR assays in the
period immediately after transmission occurs [4, 5, 24, 31]. We do not observe
s precisely. Instead, we observe the pair of times (L, R), where R < s < L.
We define L as the time of the last negative test and R as the time of the first
positive test. If the infant never has a negative test, without loss of generality,
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we set L = −∞. If instead the infant never has a positive test, we set R = ∞
and treat the observation as right-censored. Given the observed pair (L, R), we
can estimate the distribution of s, f (s), or its associated survival distribution,
S(s), using interval-censoring estimation techniques, but often we are interested
in estimating this distribution over a specific time interval. For example, when
examining the late postnatal transmission distribution, we might be interested in
estimating the effect of a set of covariates, X, on the timing of transmission after
a certain age, t1 , g1 (s|X) = f (s|s > t1 , X), where t1 is often taken to be 6 weeks.
Many infants’ observations of (L, R) will contain t1 and therefore it is unclear if
they belong to the analysis subset of interest thereby complicating estimation of
g1 (s|X). Alternatively, we might be interested in examining the effect of covariates
on the timing of MTCT in that group of subjects who are infected late postnally,
g2 (s|X) = f (s|t1 < s < t2 , X), where t2 is usally taken to be the end of follow-up.
Again, for many infants, (L, R) will contain either t1 or t2 , and it will be unclear
if they should be members of the analysis subset of interest.
To allow straight-forward estimation of both g1 and g2 , we propose a multiple
imputation (MI) technique for the actual random variable of interest, s. First, we
specify a likelihood-based model for the complete data. Next, we set prior distributions for the parameters in the model. The imputations can then be generated
using Markov Chain Monte Carlo (MCMC) methods, where, after a significant
burn-in period, the missing data is imputed by taking draws from the posterior
predictive distribution conditional on the current draws of the parameters from the
posterior distribution of the paramters. Each data set created by this imputation
technique is referred to as an augmented data set.

5
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Our proposed imputation model reflects features seen in but not unique to MTCT
studies. First, many infants are infected in utero and their infection can be detected immediately after birth. Second, because the at-risk time for MTCT of
HIV is limited by exposure to breast milk, not all subjects will experience MTCT
of HIV. This is in contrast to a usual time to event analysis where we assume
that if we could follow a subject indefinitely and there were no competing risks,
s/he would eventually experience the event. Third, s is not observed past some
end of follow-up time, t2 . To accomodate this, we will assume that all infants
are censored at t2 if they have not yet experienced the event and account for
this accordingly in the multiple imputation. This assumption will still allow for
estimation of both g1 and g2 .

2.2

Analyses models

To motivate the imputation model, we first describe two analyses of interest for
estimating late postnatal transmission in HPTN 024. The first is estimation of the
cumulative risk of MTCT of HIV-1 at the end of the study in those infants at-risk
for late postnatal transmission. The second is estimation of proportional hazards
models for late postnatal transmission. For the observed data, these analyses will
be performed subsetting the data to those infants who have a negative test at 4-8
weeks and are still breastfeeding. For the MI analyses, the data will be subsetted
to those infants with s > 6 weeks who are still breastfeeding at 6 weeks.
Censoring can be complex in these studies due to the different causes: death,
weaning and loss to follow-up; therefore, we propose examining different censoring
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rules in the analyses and in simulations to determine which censoring approach
produces the best estimate of the survival distribution or association parameter
of interest. If an infant dies, is lost to follow-up or reaches the end of the study
without having a positive HIV-1 test, his/her time to event is censored at the time
of the last negative test. If infant is weaned, there are three censoring options:

C1 An infant’s event time is censored at his last negative test. This is a common
approach that does not require information on weaning.
C2 An infant’s event time is censored at the end of follow-up if there is a negative
test after weaning in the observed data. This censoring approach reflects
that these infants are no longer at risk after weaning and should produce an
estimate of distribution of time to first positive test in the population under
study.
C3 In the observed data analysis, if an infant has a negative test after weaning,
his event time is censored at the time of weaning. Otherwise, it is censored at
the time of his last negative test. In the imputed data, an infant is censored
at the time of weaning if he has not already experienced the event. This
approach estimates the late postnatal time to first positive distribution as if
no weaning occured.

Scenarios C1 and C2 result in the same censoring scenario for the MI analysis,
no censoring except at the end of the follow-up time. However, MI results under
these scenarios will be presented as coming from Scenario C2. Under a frequent
testing schedule, there should be little difference between Scenarios C1 and C3.

7
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2.3

Imputation model

We now present the model for imputing individual times to detectable HIV-1
infection. Let si , i = 1, . . . , N denote the age at which the ith infant born to
an HIV–infected mother first has detectable HIV infection. This step requires
specifying a likelihood for the complete data. As stated in the Introduction,
there are three features of the distribution of the timing of MTCT of HIV that
the likelihood should reflect. First, most transmissions that occur in utero can
be detected immediately after birth. One way to approach this is to treat the
time to detectable infection for these infants as left censored at zero; however, we
are not really interested in estimating the timing of detectable infection before
birth. Instead, without loss of generality, we will assume the time of first positive
test for these infants is 0. Second, all infants will be weaned at some point and
will no longer be at risk; therefore, if they have not experienced MTCT before
weaning, we do not expect that they will experience it all. The third feature is
closely related to the second. Most studies, including HPTN 024 do not follow
infants until the last infant is weaned, but instead follow them for 12-18 months.
Because, in general, we do not observe events past the period of follow-up, we
cannot expect to accurately impute event times past this time. Additionally,
any analysis we might perform, even had we completely observed the outcome of
interest according to the study design, would be limited to the period of follow-up,
and it would be impossible to distinguish those infants who will never be infected
from the few who are infected after the end of follow-up. Therefore, we propose
an imputation model that is a mixture of three distributions: a point mass at
zero that reflects the proportion of infants with detectable infection at birth, a
continuous distribution for those infections that are first detectable after birth
8
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and before the end of study time, t2 , and a point mass at a time greater than t2
representing the proportion who experience the event after t2 or never experience
the event. The third distribution results in an overall distribution similar to a cure
rate mixture model ([2, 6, 14] and others) without the medical concept of cure.
Therefore, we can express the distribution of the ith infant’s time to detectable
infection as

f (si |Zi , p1 , p2 , Θ) = p1 δ0 (si ) + p2 f2 (si |Zi , p1 , p2 , Θ) + (1 − p1 − p2 )δ∞ (si ), (2.1)

where δx (si ) denotes a point mass at si = x, p1 and p2 are mixing proportions, Θ
is the set of parameters that define f2 and Zi is a vector of covariates (inlcuding
an intercept term) of length q that includes any covariates of interest for the final
analysis. To facilitate estimation, we introduce a latent (auxilliary) variable, di ,
where
di =





1,





2,






 3,

if si ∼ δ0
if si ∼ f2 (si |Zi , p1 , p2 , Θ) .
if si ∼ δ∞

Therefore, we can rewrite (2.1) conditional on di as

f (si |Zi , di , Θ) = δ0 (si )I(di =1) f2 (si |Zi , Θ)I(di =2) δ∞ (si )I(di =3) ,

(2.2)

where I(x) is an indicator function that takes on the value 1 if x is true, 0 otherwise. Here, di is a partially observed latent variable. In order to completely
specify the likelihood for imputation, we must specify a distribution for di . We
take di to be a multinomial random variable and specify its mean vector as a

9
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function of the set of covariates, Zi , such that
P r(di = 1|Zi ) = expit(α0 Zi )

(2.3)

P r(di = 2|Zi , di > 1) = expit(ω 0 Zi )

(2.4)

and

where expit is the inverse-logit function and α and ω are sets of covariates linking
Zi to di . The probability mass function for di is then
p(di |α, ω) = expit(α0 Zi )I(di =1) {expit(ω 0 Zi )[1 − expit(α0 Zi )]}I(di =2) ×
{1 − expit(α0 Zi ) − expit(ω 0 Zi )[1 − expit(α0 Zi )]}I(di =3) .

Next, we specify f2 . For ease of computation, we restrict our options to parameteric distributions. The Weibull distribution allows for a wide range of shapes for
the hazard function given by

h(t) = ata−1 exp(β 0 Zi ),

(2.5)

where a is the shape parameter of the Weibull distribution and β is a vector
of parameters linking the ith infant’s covariate vector, Zi , to the hazard and
exp(−β 0 Zi ) is the ith infant’s scale parameter. The hazard shown in (2.5) assumes
a proportional hazards model.
A frailty model may define a common scale parameter within groups, thereby
recognizing that some groups may inherently be at higher risk than other groups
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throughout follow-up. Instead, we explore the possibility that different groups
may follow hazards with different shapes without specifying membership in the
groups a priori. This approach is motivated by the hypothesis that infants’ underlying risks may follow different trajectories based on unobserved information.
For example, mixed feeding (breastfeeding plus formula or other foods) may put
infants at a higher risk of transmission [3], resulting in an underlying hazard that
may remain constant or increase rapidly after irth; whereas, exclusively breastfed
infants may be expected to have a hazard that decreases soon after birth then
becomes roughly constant [16]. In HPTN 024, information about mixed feeding
is not collected. Therefore, we allow the shape parameter to vary across infants
to accommodate this potential variation in shape of the underlying hazards. We
define γ to be a vector of length m and the ith infant’s hazard function to be

h(t) = γki tγki −1 exp(β 0 Zi ),

where ki takes on values from 1 to m and indicates which of the m elements of γ
determines the ith infant’s hazard function. Additionally, we assume the latent
variable ki follows a multinomial distribution such that

ki ∼ multinomial(πγ1 , . . . , πγm ),

where

Pm

l=1

πγl = 1. Therefore, conditional on ki , f2 is a Weibull distribution,

where
0

γki −1

f2 (si |Zi , β, γ, ki ) = γki eβ Zi si

0

γk

exp(−eβ Zi si i ).

(2.6)

Thus far, we have described the distribution of the true but unobserved time until
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an infant would first test positive for HIV-1, si . We do not actually observe si
but instead observe (Li , Ri ) and therefore need to express the likelihood in terms
of (Li , Ri ). The ith subject’s contribution to the likelihood is then

Li (γ, β, α, π, ω|Li , Ri , Zi , di , ki ) = P r(Li < si < Ri |Zi , Θ, di , ki )p(di |Zi , α)p(ki )
=

Z

Ri

Li

f (u|Zi , p1 , p2 , γ, β, ki )du expit(α0 Zi )I(di =2) ×

{expit(ω 0 Zi )[1 − expit(α0 Zi )]}I(di =1) ×
{1 − expit(α0 Zi ) − expit(ω 0 Zi )[1 − expit(α0 Zi )]}I(di =3)
m
Y

i =l)
πγI(k
.
l

l=1

2.4

Estimation procedure

Before producing estimates of the parameters in Equation 2.7, we first specify
prior distributions for these parameters as follows:

(πγ1 , . . . , πγm ) ∼ Dirichlet(1m ), where 1m is a vector of ones of length m,
βj ∼ N (0, 1000), j = 1, . . . , q,
γj ∼ N (0, 10)I(γj > 0), j = 1, . . . , m,
ω1 ∼ N (−2, 1), ωj ∼ N (0, 1000), j = 2, . . . , q,
α1 ∼ N (−2, 1), and αj ∼ N (0, 1000), j = 2, . . . , q.

We implement the mulitple imputation scheme in BUGS [25], using OpenBUGS [28]
and the BRugs package in R [19].

12
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3

Data Analysis

In this section, we apply the multiple imputation model for timing of MTCT
transmission of HIV-1 to data collected in HIV Prevention Trials Network (HPTN)
024 [26]. Although HIV testing was initially scheduled to be done at birth, 4-6
weeks and 3, 6, 9 and 12 months, the majority of 4-6 week visits occurred between
6 and 8 weeks, and the three month visit was dropped early in the study. Samples
collected at 3, 6 and 9 months were only tested if the 12 month sample was positive
or missing.
Infants born to HIV-1-infected mothers are only at risk for MTCT of HIV while
breastfeeding. At one site, mothers were counseled to stop breastfeeding by the
time their infants reached 6 months of age, and, by 6 months of age, over 90% of
the the infants at this site had been weaned. In contrast, over 90% of the infants
at the 3 remaining sites were still breastfeeding at six months. This difference
in the underlying hazard between the sites will be accounted for by performing a
stratified proportional hazards analysis.
We performed the multiple imputation as described previously. The values for
Li and Ri were discussed in general in the Methods section. Here, we discuss
how they were set more specifically for HPTN 024. If the ith infant never had a
negative test, we set Li = 0 and Ri equal to the time of the first positive test.
Because the earliest detection time is birth, Li = 0 is as general as L = −∞
in implementation. If the first positive test occured on the day of birth, we set
Li = Ri = 0. For these infants, we know that di = 1 and si = 0. If the infant had
both a negative and positive test before weaning, we set Li equal to the time of

13
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the last negative test and Ri equal to the time of the first positive test. If weaning
occured before the first positive test, we set Ri equal to the time of weaning
plus 30 days (due to the sensitivity issue discussed perviously). For subjects who
have both a positive and negative test, di is known to be 2. For subject’s with
only negative tests and no positive tests, we set Li equal to the time of the last
negative test unless weaning occured more than 30 days before the negative test.
In that case, we set Li equal to the time of weaning plus 30 days. Additionally,
because follow-up was limited to approximately one year and therefore there was
no information past this point in terms of observed events, Ri was set to 400 days.
This would not impact the final analysis where the imputed data was censored at
one year.
The following auxiliary variables were used in the imputation procedure: maternal CD4 count, hemoglogin, viral load, weight and age at 32 weeks gestation;
enrollment site; whether the mother took nevirapine; an indicator of whether the
infant was delivered at the study clinic; whether the infant took nevirapine; the
duration of ruptured membranes; and the infant’s birthweight and sex.
In each augmented data set, every infant has an imputed value for si . This si
reflects the true time of detectable infection if other events, such as death or
weaning, did not intervene. Also, because there was little information past one
year in the original data set, we censor the infants’ times to event at one year in the
final analyses. Because si is now on a continuous scale in the augmented data set,
we can perform time to breastfeeding transmission by subsetting to those subjects
whose si is greater than 6 weeks. In contrast, the observed analysis must define
the subset of interest as those infants with a negative test after 4 weeks and not

14
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positive before 8 weeks, misclassifying those infants tests at 8 weeks who may have
tested negative at 6 weeks and those infants who tested negative at 4 weeks may
test positive by 6 weeks. Therefore, we expect some bias in the baseline number
at risk. Additionally, when performing the observed data analysis, we assumed
only right censoring and set the time to event for any infant with a positive test to
be the midpoint between the last negative test and the first positive test. In the
proportional hazards model, we studied the relationship between maternal CD4
and viral load, stratified by site.
Overall for the observed analysis, of the 1977 potential infants, 1317 tested negative after the 4-8 week visit and were still breastfeeding at 8 weeks. Infants
were excluded because they were known to be positive by 8 weeks (N=298), were
weaned before 8 weeks and therefore not at risk (N=70), had unknown infection
status at 4-8 weeks due to missing 4-8 week test and later positive test (N=22),
or had no test results after the 4-8 week visit (N=270). Analyses on the observed
data were carried out under all three censoring scenarios (C1-C3). Analyses on
the augemnted data sets were carried out under censoring scenarios C2 and C3.

[Table 1 about here.]

Table 1 shows results from the Kaplan-Meier (KM) and proportional hazards
(PH) analyses on both the observed and imputed data. For the observed data,
C1 and C2 produce similar results. If all infants were tested at the end of the
study, we expect these results to be identical because all weaned infants who did
not experience MTCT of HIV would be censored after the end of follow-up. For
the observed data, censoring scenario C3 resulted in higher KM estimates of the
15
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cumulative infection rates than C1 or C2. Because C3 treats weaned infants as
if they were still at risk at the time of the weaning and therefore assumes that
some would experience the event, we would expect the proportion to be higher.
The same differences between C2 and C3 are seen in the multiple imputation
analysis. Because censoring under C2 (not at risk after weaning) is usually of
interest, we will focus the comparison between the observed and MI analyses
under censoring scenario C2. Many infants who test negative at 4-8 weeks do not
have another test result available until 12 months and that test result is positive;
therefore, because the time of the first positive test for these infants is imputed
to be approximately 7 months in the observed analysis, we expect the observed
data analyses to underestimate the transmission rate at earlier times. The results
indicate that the MI may be correcting this, producing higher estimates at 3 and 6
months than the observed analysis. MI produces lower estimates of transmission
rates at 9 and 12 months, though. The simulations summarized in the next section
show that we expect the observed analysis to overestimate the transmission rate at
12 months. Also, the MI analyses include the 294 above who have no test results
after 4-8 weeks. Potentially, these infants were less likely to have experienced
MTCT, thus increasing the number at risk disproportionately to the number of
events. The MI results do not vary substantially over m.

[Figure 1 about here.]

To better understand the variability between imputations and how the estimates
from the augmented data sets compare to the observed analysis, we plotted the
KM estimates of the cumulative infection rate curves for each augmented data set
(m = 2) and for the observed data (Figure 1). There is variability between the
16
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estimates from the augmented data sets. At most points of interest the estimates
are all contained within an interval of width approximately equal to 0.02. Before
five months, the observed data analysis estimates of the survival curve are higher
than all the estimates from the augmented data sets. From 5 to 8 months, the
observed curve crosses all the augmented data set estimates. After 8 months, the
observed curve is at the lower end of the augmented data estimates.
Also shown in Table 1 are proportional hazards regression models fit to the observed and MI data. The estimate of association was higher in the observed
analyses than in the MI analyses. Additionally, the standard errors were lower
for viral load and higher for CD4 count in the MI analyses. The MI results varied little over m or the censoring scenario. However, the observed analyses results
varied more over censoring scenarios (C3 vs. C2 or C1), suggesting some interplay
between timing of weaning and CD4 count and viral load.

4

Simulations

In this section, we describe simulations designed to assess the multiple imputation
procedure and compare it to traditional analyses on the observed data. Additionally, we explored the three censoring approaches for weaning (C1-C3). We simulated di and si subject to the effects of 4 covariates, 2 binary (X1 ∼ bernoulli(.5),
X2 ∼ bernoulli(.25)) and 2 continunous (X3 ∼ uniform(−1, 1), X4 ∼ N (0, 1),
with m = 2, γ = (7, 0.9), P r(ki = 1) = 0.26, α = (−2.7, −1.0, 1.0, 0.5, −1.0),
ω = (−0.5, −2.0, 2.0, 0.5, −1.0) and β = (−1.6, −1.0, 1.0, −0.5, 0.5).

17
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We then simulated visits according to visit schedule in HPTN 024 (birth, 4-8 weeks
and 3, 6, 9 and 12 months) and according to the proportions seen in HPTN 024.
Specifically, we sampled attendence at first and second visits with probabilities
equal to 0.94 and 0.85 respectively. If the infant had a negative test at either
birth or 4-8 weeks, then he had a test result at 12 months with probability equal
to 0.80. If the infant missed both the birth and 4-8 week visit, he had a test result
from the one year visit with probability equal to 0.20. If the infant missed the 12
month visit, he had a test result from the 9 month visit with probability equal to
0.50. If subject tested positive at the 12 month visit, he had a sample from the
9 month visit with probability equal to 0.80. If the infant missed the 9 and 12
month visits, he had a test result from the 6 month visit with probability equal
to 0.60. If subject was positive at the 9 month visit, he had a test result from the
6 month visit with probability equal to 0.80. If the infant missed the 6, 9 or 12
month visit, he had a test result from the 3 month visit with probability equal to
0.20. If the infant had a positive test result from the 6 month visit, he had a test
result from 3 months with probability equal to 0.40. At each visit, his visit time
was simulated according to the observed distribution of visits in HPTN 024.
Next, we simulated times of death and weaning according to the distributions seen
in HPTN 024 under the following three scenarios:

S1 Non-informative loss to follow-up and death and no weaning
S2 Non-informative loss to follow-up, death related to one of the covariates (X3 )
in the same manner as CD4 count is related to infant death in HPTN 024 and
no weaning.

18
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S3 Non-informative loss to follow-up, death and weaning.
S4 Non-informative loss to follow-up and death. Time to weaning is related to X2
similarly to the relationship between the HPTN 024 site with early weaning
and time to weaning. Therefore, X2 = 1 is associated with early weaning and
increased risk of transmission.

Under each scenario, we simulated 100 data sets with 1000 observations each and
fit the complete data analysis (no censoring except for death) which was used as
the gold standard for comparing the observed data analysis and the MI analysis
with m = 1, 2, 3 under S1 and S2. For S3 and S4, we compared the results to
two gold standards designed to represent the best estimates possible if we had
observed timing of detectable infection perfectly. The first gold standard (G1)
censors infants at death. The second gold standard (G2) censors infants at death
and weaning and estimates transmission rates and associations assuming there
was no weaning. C2 is designed to estimate the first gold standard, and C3 is
designed to estimate the second gold standard. C1 mimics what is usually done
in practice.
We compared the results in terms of their bias compared to the gold standard, the
variance ratio (variance of the estimate of the analysis divided by the variance of
the gold standard analysis) and the coverage rates (frequency that the confidence
interval contained the gold standard estimate).
The results for the simulations under S1 and S2 are shown in Table 2. The MI
analyses performed the same or better in terms of bias under both scenarios for
both estimators. The MI analyses had lower variance estimates than the observed
19
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analyses for the estimate of cumulative transmission, but the opposite was true
for the estimate of the hazard ratio. The coverage rates for the MI analyses were
the same or better than the observed analyses under both scenarios.
The results for the simulations under S3 are shown in Table 3. First, we examine
estimates for the late postnatal transmission rate at 12 months. The bias for
the observed analyses was relatively high compared to the truth (0.1182) and
twice that of most of the MI analyses. Additionally, the MI analyses were more
efficient under all scenarios. The coverage rates for the MI analyses were better
for G1; however, the coverage rates for the observed analyses were better for
G2. Turning our attention to the PH analyses, the observed and MI analyses
performed similarly for bias under G1 and G2. The lowest bias was the observed
analysis under C3 for G1. In all cases, the observed analyses were more efficient
than the MI analyses. Both the observed and MI analyses had similar coverage
rates.
The results for the simulations under S4 are shown in Table 4. Under G1, MI
performed better in terms of bias for both the KM and PH estimates. Under
G2, the observed analysis performed better. Additionally, the observed analysis
produced less biased estimates of G2 and G1, even under censoring scenarios
designed to estimate G1. The MI KM analyses were more efficient than the
observed analyses for G1 and G2. The opposite was true for the PH estimates.
Recalling that C3 is designed to estimate G2, the low coverage rates for MI under
G2 using C2 is not alarming; however, the coverage rates are higher than desirable
under C3.
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5

Discussion

We present an approach to imputing the timing of MTCT of HIV-1. Given the
augmented data sets produced by the multiple imputation procedure, we can now
perform many analyses that would not be possible otherwise without excluding
large portions of the data set. Here, we showed an example estimating the cumulative late postnatal transmission rate at 12 months and the effect of covariates
on the hazard of late postnatal transmission. Additional analyses are now also
attainable. For example, investigators are also interested in estimating the distribution of timing of MTCT among those infants who experience MTCT for use in
planning HIV-1 testing schedules. Potential analyses are not limited to late postnatal transmission. For example, we may want to assess how baseline covariates
predict transmission during the three exposure periods. The MI approach allows
us to include those infants whose timing could not previously be precisely categorized. This approach is flexible and can easily be implemented with OpenBugs
and R.
The MI approach was validated in simulations and shown to be less biased in
most situations than the traditional estimator. In the presence of weaning, the
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traditional estimator proved to be a better estimator of the distribution of MTCT
ignoring weaning which is seldom of interest.
Our goal here was to find a flexible MI model that could easily be implemented
in available software. Although, the MI model we propose is flexible and mirrors
the modes of MTCT of HIV, it could be improved in several ways. Here, we do
not directly account for HIV-1-infected infants being at higher risk of death. In
reality, it is likely that an infant who had a negative test long before death actually
acquired HIV-1. Additionally, a mother’s decision to wean may also be related
to the health status of her infant. To reflect these issues, we could consider
modeling the relationship between the risk of death, time to weaning and the
risk of MTCT more directly using competing risk models. We chose mixtures of
Weibull models for flexibility in the distribution of time to detectable infection
after birth. Instead, we could explore other flexible baseline hazards; however,
these models would likely require customized software and would not be easily fit.
Lastly, we chose to impute time to detectable infection and not the actual time
to transmission. The sensitivity of the HIV-1 assays vary over time in way that is
not clearly understood. To attempt to incorporate this in the model would have
been to complex. Additionally, from a public health perspective, understanding
the timing of detectable infection is more important.
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Figure 1: Curves of the cumulative proportion infected for the observed data
analysis (black) and each of the augmented data sets (grey). The vertical lines
represent the centers of the visit windows. The crosses on the solid line indicate
where infants had a last negative test and then were subsequently lost to follow-up.
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Table 1: Results from breastfeeding transmission analyses (C1=censored at last
negative; C2=censored after end of follow-up if weaned before last negative;
C3=censored at time of weaning). (∗ estimates correspond to change in one standard deviation)
C1
C2
C3
Kaplan Meier analysis (% testing positive, std. error)
Observed
3 months
1.4 (0.32)
1.4 (0.32)
1.4 (0.33)
6 months
4.0 (0.54)
4.0 (0.54)
4.5 (0.61)
9 months
6.0 (0.66)
5.8 (0.65)
6.9 (0.77))
12 months
6.8 (0.72)
6.6 (0.70)
8.0 (0.85)
MI (m=1)
3 months
–
2.8 (0.51)
2.9 (0.52)
6 months
–
4.6 (0.60)
4.8 (0.63)
9 months
–
5.3 (0.64)
5.8 (0.69)
12 months
–
5.9 (0.67)
6.4 (0.74)
MI (m=2)
3 months
–
3.0 (0.55)
3.1 (0.56)
6 months
–
4.6 (0.61)
4.9 (0.64)
9 months
–
5.4 (0.65)
5.8 (0.70)
12 months
–
5.9 (0.68)
6.5 (0.75)
MI (m=3)
3 months
–
3.2 (0.56)
3.2 (0.57)
6 months
–
4.8 (0.64)
5.0 (0.67)
9 months
–
5.6 (0.67)
6.0 (0.72)
12 months
–
6.1 (0.70)
6.6 (0.77)
Proportional hazards analysis (coefficient, std. error
Observed
CD4 count∗ -0.695 (0.111) -0.699 (0.111) -0.757 (0.116)
viral load∗
1.077 (0.163) 1.077 (0.162) 1.088 (0.163)
MI (m=1)
CD4 count∗
–
-0.659 (0.113) -0.681 (0.114)
viral load∗
–
1.039 (0.158) 1.043 (0.158)
MI (m=2)
CD4 count∗
–
-0.650 (0.115) -0.661 (0.117)
viral load∗
–
1.040 (0.160) 1.044 (0.160)
MI (m=3)
CD4 count∗
–
-0.647 (0.114) -0.668 (0.116)
viral load∗
–
1.041 (0.155) 1.045 (0.155)
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Table 2: Simulation results when there is assumed to be no weaning during followup. S = simulation scenario, O = observed data analysis, MI = multiple imputation analysis.
Scenario
Bias
Variance ratio
S m
O
MI
O
MI
12 month estimate of MTCT
1 1
0.0187 0.0018 1.39
1.19
1 2
–
-0.0046
–
1.29
1 3
–
-0.0040
–
1.23
2 1
0.0158 -0.0110 1.47
1.08
2 2
–
-0.0159
–
1.15
2 3
–
-0.0164
–
1.14
PH estimate
1 1
0.0355 0.0037 1.05
1.19
1 2
–
0.0139
–
1.36
1 3
–
0.0018
–
1.33
2 1
0.0178 0.0040 1.22
1.41
2 2
–
0.0072
–
1.62
2 3
–
0.0003
–
1.62

Coverage rate
O
MI
0.87
–
–
0.88
–
–

0.97
0.93
0.93
0.93
0.87
0.89

0.96
–
–
0.98
–
–

0.96
0.96
0.97
0.97
0.96
0.97
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C1

12 month estimate
MI
Observed
C2
C3
C2
C3
C1

0.96
0.98
0.97

0.95
0.95
0.96

0.96
0.96
0.96

1.40
1.58
1.59

1.40
1.58
1.59

0.95
0.94
0.95

1.26
1.43
1.44

-0.0035
0.0094
0.0101

0.0153
0.0298
0.01685

1.26
1.43
1.44

-0.0240
-0.0202
-0.0104

-0.0051
0.0002
0.0036

PH estimate
Observed
MI
C2
C3
C2
C3

Bias
gold standard censored at death (G1; KM=0.118, PH=-1.30)
1 0.0213 0.0204 0.0380 -0.0080 0.0096 0.0044 0.0047 -0.0003
2
–
–
-0.0156 0.0014
–
–
–
–
3
–
–
-0.0089 0.0026
–
–
–
–
gold standard censored at death/weaning (G2; KM=0.137, PH =-1.32)
1 0.0079 0.0070 0.0246 -0.0214 -0.0038 0.0249 0.0252 0.0202
2
–
–
-0.0290 -0.0120
–
–
–
–
–
–
-0.0223 -0.0108
–
–
–
3
–
Variance ratio
gold standard censored at death (G1)
1.42
1.88
1.02
1.42
1.03
1.03
1.03
1
1.44
2
–
–
–
1.108
1.48
–
–
–
3
–
–
1.18
1.46
–
–
–
–
gold standard censored at death/weaning (G2)
1
1.27
1.25
1.67
0.90
1.25
1.14
1.14
1.14
2
–
–
–
0.96
1.31
–
–
–
3
–
–
–
1.05
1.29
–
–
–
Coverage rates
gold standard censored at death (G1)
1
0.87
0.88
0.57
0.93
1.00
0.95
0.94
0.95
2
–
–
–
0.82
1.00
–
–
–
3
–
–
–
0.92
1.00
–
–
–
gold standard censored at death/weaning (G2)
1
0.97
0.97
0.82
0.63
1.00
0.95
0.94
0.95
2
–
–
–
0.55
1.00
–
–
–
3
–
–
–
0.88
1.00
–
–
–

m

Table 3: Simulation results when weaning is observed during follow-up.
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C1

12 month estimate
MI
Observed
C2
C3
C2
C3
C1

1.32
1.53
1.51
1.75
2.25
2.00

0.98
0.99
1.00
0.96
0.97
0.96

1.76
2.25
2.01

0.99
0.99
1.00
0.95
0.97
0.95

-0.2327
-0.1941
-0.192

-0.2444
-0.2170
-0.214

1.33
1.53
1.52

-0.0188
-0.0202
-0.0127

-0.0412
-0.0295
-0.0348

PH estimate
Observed
MI
C2
C3
C2
C3

Bias
gold standard censored at death (G1; KM=0.113, PH=-1.51)
1 0.0187 0.0179 0.0353 -0.0057 0.0057 0.0627 0.0613 0.0955
2
–
–
-0.0115 -0.0003
–
–
–
–
3
–
–
-0.0180 -0.0006
–
–
–
–
gold standard censored at death/weaning (G2; KM=0.136, PH=-1.33)
1 -0.0046 -0.0054 0.0120 -0.0295 -0.0180 -0.1170 -0.1184 -0.0842
2
–
–
0.0352 0.0240
–
–
–
–
–
–
-0.0353 -0.0243
–
–
–
3
–
Variance ratio
gold standard censored at death
1.41
1.89
1.09
1.39
1.01
1.01
1.01
1
1.43
2
–
–
–
1.16
1.46
–
–
–
3
–
–
1.15
1.44
–
–
–
–
gold standard censored at death/weaning
1
1.15
1.13
1.52
0.88
1.11
1.48
1.48
1.48
2
–
–
–
0.93
1.17
–
–
–
3
–
–
–
0.92
1.15
–
–
–
Coverage rates
gold standard censored at death
1
0.91
0.91
0.54
0.98
0.98
0.93
0.93
0.92
2
–
–
–
0.92
0.99
–
–
–
3
–
–
–
0.91
0.99
–
–
–
gold standard censored at death/weaning
1
0.98
0.98
0.98
0.48
1.00
0.96
0.96
0.97
2
–
–
–
0.29
1.00
–
–
–
3
–
–
–
0.32
1.00
–
–
–

m

Table 4: Simulation results when weaning related to a covariate is observed during follow-up.

